This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medivo Acquires Top-Rated Mobile App, OnTrack Diabetes

Medivo Inc. today announced that it has acquired OnTrack Diabetes as part of the company’s continued focus to help physicians with patient treatment and care. This top-rated app will be instrumental in helping physicians coordinate patient care and can be recommended to monitor key clinical changes between office visits.

The free, highly rated app helps diabetics manage their diabetes by tracking various items such as blood glucose, food intake, medication, blood pressure (BP), pulse, exercise and weight. The app also produces charts, graphs and reports for optimal care coordination. The OnTrack app has been downloaded by more than a half million users and it has an average rating of 4.5 stars (based on 4,000 user reviews) in Google Play. It is available for Android devices.

“We are extremely excited about adding the powerful OnTrack Diabetes app as a resource for patients to monitor their symptoms and to create reports that can be shared with their physician,” said Sundeep Bhan, Chief Executive Officer and a Co-Founder of Medivo. “This acquisition also fits with our growth strategy, enhances our consumer app portfolio and furthers our plans to develop new patient and physician engagement services.”

OnTrack Diabetes was developed by GExperts Inc. of Newmarket, Ontario. The app’s features include an easy-to-use interface that simplifies adding new entries, a variety of useful graphs and reports, a detailed log book that is easily shared with a physician and a functional reminder program that can be set to alert users to glucose test two hours after eating.

The OnTrack Diabetes app adds to Medivo’s mobile app portfolio, which includes apps for the management of inflammatory bowel disease (IBD) / Crohn’s and ulcerative colitis; hereditary angioedema (HAE), and chronic myelogenous leukemia (CML). Medivo’s apps allow patients to easily track symptoms, view recent lab results and communicate with fellow patients in real-time.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,829.33 -82.78 -0.49%
S&P 500 1,967.67 -2.28 -0.12%
NASDAQ 4,455.3480 +12.65 0.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs